Post by DISCO Pharmaceuticals GmbH

DISCO is headed to San Francisco for #JPM2026   Connect with our CEO, Mark Manfredi and CBO, Ajla Hrle at J.P. Morgan 44th Annual Healthcare Conference to learn more about how DISCO uncovers novel cell surface target pairs to advance highly-selective surfacome-targeted therapies. #Surfaceome #TargetedTherapies #CancerResearch #DrugDiscovery